Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tandem mass spectrometry screening: proving effectiveness.

R J Pollitt1

  • 1Neonatal Screening Laboratory, Sheffield Children's Hospital, UK. Rodney.Pollitt@sheffch-tr.trent.nhs.uk

Acta Paediatrica (Oslo, Norway : 1992). Supplement
|January 8, 2000
PubMed
Summary

Tandem mass spectrometry (TMS) shows promise for newborn screening, but validation of follow-up protocols and comparison with existing methods are crucial. Careful interpretation of results, considering clinical factors, is essential for accurate diagnosis and patient management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Commentary: What degree of hyperphenylalaninaemia requires treatment?

Journal of inherited metabolic disease·2012
Same author

Newborn blood spot screening: new opportunities, old problems.

Journal of inherited metabolic disease·2009
Same author

Qualitative urinary organic acid analysis: methodological approaches and performance.

Journal of inherited metabolic disease·2008
Same author

Introducing new screens: why are we all doing different things?

Journal of inherited metabolic disease·2007
Same author

Population quantile-quantile plots for monitoring assay performance in newborn screening.

Journal of inherited metabolic disease·2007
Same author

International perspectives on newborn screening.

Journal of inherited metabolic disease·2006

Area of Science:

  • Biochemistry
  • Medical Diagnostics
  • Public Health

Background:

  • Emerging literature on tandem mass spectrometry (TMS) for newborn screening highlights uncertainties in test performance.
  • Existing diagnostic methods and follow-up protocols require formalization and validation for TMS-based screening.

Purpose of the Study:

  • To address uncertainties in tandem mass spectrometry (TMS) test performance for newborn screening.
  • To emphasize the need for validating follow-up protocols and comparing TMS with established diagnostic techniques.

Main Methods:

  • Comparative analysis of tandem mass spectrometry (TMS) sensitivity against traditional diagnostic methods.
  • Setting screening cut-offs based on clinical, not analytical, criteria.
  • Comparing presumptive positive cases from acylcarnitine profiling with clinically diagnosed symptomatic cases.

Related Experiment Videos

Main Results:

  • Tandem mass spectrometry (TMS) may exhibit varying sensitivities for different diseases compared to previous methods.
  • Potential for over-sensitivity in TMS, leading to diagnosis of mild variants or non-disease states.
  • Mutation analysis should be used cautiously as the sole diagnostic criterion.

Conclusions:

  • Formalizing and validating follow-up protocols for tandem mass spectrometry (TMS) screening is essential.
  • Clinical criteria should guide the setting of screening cut-offs to ensure accurate diagnosis.
  • Registration and long-term surveillance of all detected cases are recommended for comprehensive evaluation.